ID   IPYR2_HUMAN             Reviewed;         334 AA.
AC   Q9H2U2; B4DLP7; F8WDN9; I6L9B6; Q4W5E9; Q6PG51; Q8TBW0; Q96E55;
AC   Q9H0T0; Q9NX37; Q9P033; Q9ULX0;
DT   27-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   15-MAR-2017, entry version 143.
DE   RecName: Full=Inorganic pyrophosphatase 2, mitochondrial;
DE            EC=3.6.1.1;
DE   AltName: Full=Pyrophosphatase SID6-306;
DE   AltName: Full=Pyrophosphate phospho-hydrolase 2;
DE            Short=PPase 2;
DE   Flags: Precursor;
GN   Name=PPA2; ORFNames=HSPC124;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RA   Saito T., Hattori A., Miyajima N.;
RT   "Putative inorganic pyrophosphatase.";
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Kanni L., Johansson M., Karlsson A.;
RT   "Cloning of the mitochondrial inorganic pyrophosphatase 2 cDNA.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ASN-282.
RC   TISSUE=Fibroblast, and Gastric carcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 3-334 (ISOFORM 4), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 12-334 (ISOFORM 5).
RC   TISSUE=Lung, Ovary, and Skeletal muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 13-334 (ISOFORM 2), AND
RP   VARIANT ASN-282.
RC   TISSUE=Umbilical cord blood;
RX   PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for
RT   300 previously undefined genes expressed in CD34+ hematopoietic
RT   stem/progenitor cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 19-334 (ISOFORM 2), AND
RP   VARIANT ASN-282.
RC   TISSUE=Brain;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [8]
RP   PROTEIN SEQUENCE OF 33-40.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [9]
RP   TISSUE SPECIFICITY, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15210126; DOI=10.1016/j.bbapap.2004.03.014;
RA   Afjehi-Sadat L., Krapfenbauer K., Slavc I., Fountoulakis M., Lubec G.;
RT   "Hypothetical proteins with putative enzyme activity in human amnion,
RT   lymphocyte, bronchial epithelial and kidney cell lines.";
RL   Biochim. Biophys. Acta 1700:65-74(2004).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-261, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-317, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-317, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-317, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-317, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   CLEAVAGE OF TRANSIT PEPTIDE [LARGE SCALE ANALYSIS] AFTER MET-32, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [19]
RP   FUNCTION, INVOLVEMENT IN SCFI, VARIANTS SCFI PRO-61; VAL-94; ILE-106;
RP   LYS-172 AND PRO-294, AND CHARACTERIZATION OF VARIANTS SCFI PRO-61 AND
RP   LYS-172.
RX   PubMed=27523598; DOI=10.1016/j.ajhg.2016.06.021;
RA   Guimier A., Gordon C.T., Godard F., Ravenscroft G., Oufadem M.,
RA   Vasnier C., Rambaud C., Nitschke P., Bole-Feysot C., Masson C.,
RA   Dauger S., Longman C., Laing N.G., Kugener B., Bonnet D.,
RA   Bouvagnet P., Di Filippo S., Probst V., Redon R., Charron P.,
RA   Roetig A., Lyonnet S., Dautant A., de Pontual L., di Rago J.P.,
RA   Delahodde A., Amiel J.;
RT   "Biallelic PPA2 mutations cause sudden unexpected cardiac arrest in
RT   infancy.";
RL   Am. J. Hum. Genet. 99:666-673(2016).
RN   [20]
RP   FUNCTION, INVOLVEMENT IN SCFAI, INVOLVEMENT IN SCFI, VARIANTS SCFI
RP   LEU-127 AND LEU-167, CHARACTERIZATION OF VARIANT SCFI LEU-167,
RP   VARIANTS SCFAI LYS-172 AND LEU-228, AND CHARACTERIZATION OF VARIANTS
RP   SCFAI LYS-172 AND LEU-228.
RX   PubMed=27523597; DOI=10.1016/j.ajhg.2016.06.027;
RA   Kennedy H., Haack T.B., Hartill V., Matakovic L., Baumgartner E.R.,
RA   Potter H., Mackay R., Alston C.L., O'Sullivan S., McFarland R.,
RA   Connolly G., Gannon C., King R., Mead S., Crozier I., Chan W.,
RA   Florkowski C.M., Sage M., Hoefken T., Alhaddad B., Kremer L.S.,
RA   Kopajtich R., Feichtinger R.G., Sperl W., Rodenburg R.J., Minet J.C.,
RA   Dobbie A., Strom T.M., Meitinger T., George P.M., Johnson C.A.,
RA   Taylor R.W., Prokisch H., Doudney K., Mayr J.A.;
RT   "Sudden cardiac death due to deficiency of the mitochondrial inorganic
RT   pyrophosphatase PPA2.";
RL   Am. J. Hum. Genet. 99:674-682(2016).
CC   -!- FUNCTION: Hydrolyzes inorganic pyrophosphate (PubMed:27523597).
CC       This activity is essential for correct regulation of mitochondrial
CC       membrane potential, and mitochondrial organization and function
CC       (PubMed:27523598). {ECO:0000269|PubMed:27523597,
CC       ECO:0000269|PubMed:27523598}.
CC   -!- CATALYTIC ACTIVITY: Diphosphate + H(2)O = 2 phosphate.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q9H2U2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H2U2-2; Sequence=VSP_011651;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=3;
CC         IsoId=Q9H2U2-3; Sequence=VSP_011652;
CC       Name=4;
CC         IsoId=Q9H2U2-4; Sequence=VSP_011649, VSP_011650;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q9H2U2-6; Sequence=VSP_046256;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Detected in brain, gastric carcinoma, lung,
CC       ovary, skeletal muscle, umbilical cord blood and a cell line
CC       derived from kidney proximal tubule epithelium.
CC       {ECO:0000269|PubMed:15210126}.
CC   -!- DISEASE: Sudden cardiac failure, alcohol-induced (SCFAI)
CC       [MIM:617223]: An autosomal recessive disease characterized by
CC       sudden death due to unexpected cardiac arrest following ingestion
CC       of small amounts of alcohol. {ECO:0000269|PubMed:27523597}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Sudden cardiac failure, infantile (SCFI) [MIM:617222]: A
CC       disease characterized by sudden death within the first 2 years of
CC       life due to unexpected cardiac arrest. Some patients manifest
CC       hypertrophic cardiomyopathy, lipid accumulation in myocardium,
CC       degeneration of mitochondrial cristae, metabolic acidosis, and
CC       elevated plasma lactate levels. SCFI transmission pattern is
CC       consistent with autosomal recessive inheritance.
CC       {ECO:0000269|PubMed:27523597, ECO:0000269|PubMed:27523598}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the PPase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF29088.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAF29088.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};
CC       Sequence=BAA84701.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA91184.1; Type=Erroneous termination; Positions=59; Note=Translated as Tyr.; Evidence={ECO:0000305};
CC       Sequence=BAG59609.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC       Sequence=CAB66590.2; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAB66590.2; Type=Frameshift; Positions=75; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB026722; BAA84701.1; ALT_INIT; mRNA.
DR   EMBL; AF217187; AAG36781.1; -; mRNA.
DR   EMBL; AK000466; BAA91184.1; ALT_SEQ; mRNA.
DR   EMBL; AK297096; BAG59609.1; ALT_SEQ; mRNA.
DR   EMBL; AC004066; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC106888; AAY41040.1; -; Genomic_DNA.
DR   EMBL; BC022803; AAH22803.1; -; mRNA.
DR   EMBL; BC039462; AAH39462.2; -; mRNA.
DR   EMBL; BC057219; AAH57219.1; -; mRNA.
DR   EMBL; AF161473; AAF29088.1; ALT_SEQ; mRNA.
DR   EMBL; AL136655; CAB66590.2; ALT_SEQ; mRNA.
DR   CCDS; CCDS34043.1; -. [Q9H2U2-4]
DR   CCDS; CCDS3667.1; -. [Q9H2U2-1]
DR   CCDS; CCDS3668.2; -. [Q9H2U2-3]
DR   CCDS; CCDS3669.2; -. [Q9H2U2-6]
DR   RefSeq; NP_008834.3; NM_006903.4. [Q9H2U2-3]
DR   RefSeq; NP_789842.2; NM_176866.2. [Q9H2U2-6]
DR   RefSeq; NP_789843.2; NM_176867.3. [Q9H2U2-4]
DR   RefSeq; NP_789845.1; NM_176869.2. [Q9H2U2-1]
DR   UniGene; Hs.654957; -.
DR   ProteinModelPortal; Q9H2U2; -.
DR   SMR; Q9H2U2; -.
DR   BioGrid; 117979; 38.
DR   IntAct; Q9H2U2; 5.
DR   MINT; MINT-3066899; -.
DR   STRING; 9606.ENSP00000343885; -.
DR   iPTMnet; Q9H2U2; -.
DR   PhosphoSitePlus; Q9H2U2; -.
DR   SwissPalm; Q9H2U2; -.
DR   BioMuta; PPA2; -.
DR   DMDM; 116242592; -.
DR   OGP; Q9H2U2; -.
DR   EPD; Q9H2U2; -.
DR   MaxQB; Q9H2U2; -.
DR   PaxDb; Q9H2U2; -.
DR   PeptideAtlas; Q9H2U2; -.
DR   PRIDE; Q9H2U2; -.
DR   DNASU; 27068; -.
DR   Ensembl; ENST00000341695; ENSP00000343885; ENSG00000138777. [Q9H2U2-1]
DR   Ensembl; ENST00000348706; ENSP00000313061; ENSG00000138777. [Q9H2U2-3]
DR   Ensembl; ENST00000354147; ENSP00000340352; ENSG00000138777. [Q9H2U2-4]
DR   Ensembl; ENST00000432483; ENSP00000389957; ENSG00000138777. [Q9H2U2-6]
DR   GeneID; 27068; -.
DR   KEGG; hsa:27068; -.
DR   UCSC; uc003hxl.4; human. [Q9H2U2-1]
DR   CTD; 27068; -.
DR   DisGeNET; 27068; -.
DR   GeneCards; PPA2; -.
DR   HGNC; HGNC:28883; PPA2.
DR   HPA; HPA030888; -.
DR   HPA; HPA031671; -.
DR   HPA; HPA031672; -.
DR   MIM; 609988; gene.
DR   MIM; 617222; phenotype.
DR   MIM; 617223; phenotype.
DR   neXtProt; NX_Q9H2U2; -.
DR   OpenTargets; ENSG00000138777; -.
DR   PharmGKB; PA142671159; -.
DR   eggNOG; KOG1626; Eukaryota.
DR   eggNOG; COG0221; LUCA.
DR   GeneTree; ENSGT00390000017004; -.
DR   HOVERGEN; HBG000491; -.
DR   InParanoid; Q9H2U2; -.
DR   KO; K01507; -.
DR   OMA; ISCTNIT; -.
DR   OrthoDB; EOG091G0KFV; -.
DR   PhylomeDB; Q9H2U2; -.
DR   TreeFam; TF300887; -.
DR   BRENDA; 3.6.1.1; 2681.
DR   Reactome; R-HSA-379726; Mitochondrial tRNA aminoacylation.
DR   Reactome; R-HSA-71737; Pyrophosphate hydrolysis.
DR   ChiTaRS; PPA2; human.
DR   GenomeRNAi; 27068; -.
DR   PRO; PR:Q9H2U2; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000138777; -.
DR   CleanEx; HS_PPA2; -.
DR   ExpressionAtlas; Q9H2U2; baseline and differential.
DR   Genevisible; Q9H2U2; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0004427; F:inorganic diphosphatase activity; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004722; F:protein serine/threonine phosphatase activity; IEA:Ensembl.
DR   GO; GO:0071344; P:diphosphate metabolic process; TAS:Reactome.
DR   GO; GO:0051881; P:regulation of mitochondrial membrane potential; IMP:UniProtKB.
DR   GO; GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome.
DR   CDD; cd00412; pyrophosphatase; 1.
DR   Gene3D; 3.90.80.10; -; 1.
DR   InterPro; IPR008162; Pyrophosphatase.
DR   PANTHER; PTHR10286; PTHR10286; 1.
DR   Pfam; PF00719; Pyrophosphatase; 1.
DR   SUPFAM; SSF50324; SSF50324; 1.
DR   PROSITE; PS00387; PPASE; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Hydrolase; Magnesium;
KW   Metal-binding; Mitochondrion; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transit peptide.
FT   TRANSIT       1     32       Mitochondrion.
FT                                {ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|PubMed:12665801}.
FT   CHAIN        33    334       Inorganic pyrophosphatase 2,
FT                                mitochondrial.
FT                                /FTId=PRO_0000025411.
FT   METAL       164    164       Magnesium 1. {ECO:0000250}.
FT   METAL       169    169       Magnesium 1. {ECO:0000250}.
FT   METAL       169    169       Magnesium 2. {ECO:0000250}.
FT   METAL       201    201       Magnesium 1. {ECO:0000250}.
FT   MOD_RES     216    216       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q91VM9}.
FT   MOD_RES     224    224       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q91VM9}.
FT   MOD_RES     259    259       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q91VM9}.
FT   MOD_RES     261    261       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     317    317       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ      53     53       K -> N (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_011649.
FT   VAR_SEQ      54    219       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_011650.
FT   VAR_SEQ      74     74       E -> EDTEAQGIFIDLSKIW (in isoform 2).
FT                                {ECO:0000303|PubMed:11042152,
FT                                ECO:0000303|PubMed:11230166}.
FT                                /FTId=VSP_011651.
FT   VAR_SEQ      75    176       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_046256.
FT   VAR_SEQ     148    176       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.1}.
FT                                /FTId=VSP_011652.
FT   VARIANT      61     61       S -> P (in SCFI; loss of function in
FT                                regulation of mitochondrial membrane
FT                                potential).
FT                                {ECO:0000269|PubMed:27523598}.
FT                                /FTId=VAR_077866.
FT   VARIANT      94     94       M -> V (in SCFI).
FT                                {ECO:0000269|PubMed:27523598}.
FT                                /FTId=VAR_077867.
FT   VARIANT     106    106       M -> I (in SCFI).
FT                                {ECO:0000269|PubMed:27523598}.
FT                                /FTId=VAR_077868.
FT   VARIANT     127    127       R -> L (in SCFI; dbSNP:rs139076647).
FT                                {ECO:0000269|PubMed:27523597}.
FT                                /FTId=VAR_077869.
FT   VARIANT     167    167       P -> L (in SCFI; decreased pyroposphatase
FT                                activity; dbSNP:rs546693824).
FT                                {ECO:0000269|PubMed:27523597}.
FT                                /FTId=VAR_077870.
FT   VARIANT     172    172       E -> K (in SCFI and SCFAI; loss of
FT                                function in regulation of mitochondrial
FT                                membrane potential; decreased
FT                                pyroposphatase activity;
FT                                dbSNP:rs146013446).
FT                                {ECO:0000269|PubMed:27523597,
FT                                ECO:0000269|PubMed:27523598}.
FT                                /FTId=VAR_077871.
FT   VARIANT     228    228       P -> L (in SCFAI; decreased
FT                                pyroposphatase activity;
FT                                dbSNP:rs138215926).
FT                                {ECO:0000269|PubMed:27523597}.
FT                                /FTId=VAR_077872.
FT   VARIANT     282    282       K -> N (in dbSNP:rs13787).
FT                                {ECO:0000269|PubMed:11042152,
FT                                ECO:0000269|PubMed:11230166,
FT                                ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_019723.
FT   VARIANT     294    294       Q -> P (in SCFI).
FT                                {ECO:0000269|PubMed:27523598}.
FT                                /FTId=VAR_077873.
FT   CONFLICT     11     11       G -> V (in Ref. 1; BAA84701 and 2;
FT                                AAG36781). {ECO:0000305}.
FT   CONFLICT     19     19       R -> G (in Ref. 7; CAB66590).
FT                                {ECO:0000305}.
FT   CONFLICT    103    103       N -> K (in Ref. 7; CAB66590).
FT                                {ECO:0000305}.
FT   CONFLICT    241    241       Y -> C (in Ref. 7; CAB66590).
FT                                {ECO:0000305}.
FT   CONFLICT    288    288       I -> T (in Ref. 7; CAB66590).
FT                                {ECO:0000305}.
SQ   SEQUENCE   334 AA;  37920 MW;  F8C85F64CDA447F1 CRC64;
     MSALLRLLRT GAPAAACLRL GTSAGTGSRR AMALYHTEER GQPCSQNYRL FFKNVTGHYI
     SPFHDIPLKV NSKEENGIPM KKARNDEYEN LFNMIVEIPR WTNAKMEIAT KEPMNPIKQY
     VKDGKLRYVA NIFPYKGYIW NYGTLPQTWE DPHEKDKSTN CFGDNDPIDV CEIGSKILSC
     GEVIHVKILG ILALIDEGET DWKLIAINAN DPEASKFHDI DDVKKFKPGY LEATLNWFRL
     YKVPDGKPEN QFAFNGEFKN KAFALEVIKS THQCWKALLM KKCNGGAINC TNVQISDSPF
     RCTQEEARSL VESVSSSPNK ESNEEEQVWH FLGK
//
